≡
🔎︎
🔎︎
Roundtables
Podcasts
Viewpoints
Conferences
MEDICAL NEWS
FDA & Regulations
Policy & Legislation
Healthcare Systems & Business
Digital Health & AI
Workforce & Practice
Clinical Trial Updates
ONCOLOGY CARE
GU Cancers
Hematologic Malignancies
Breast Cancer
Lung & Thoracic
GI Cancers
Dermatologic Cancer
Supportive & Survivorship Care
PRECISION MEDICINE
Biomarker & Genomic Testing
Transplant Diagnostics
Liquid Biopsy & MRD
Companion Diagnostics
Cell & Gene Therapy
SPECIALTY MEDICINE
Cardiology
Dermatology & Allergy
Endocrinology & Metabolic
Pulmonology
GI & Hepatology
ID & Vaccines
NEUROLOGY & MENTAL HEALTH
Alzheimer's & Dementia
Multiple Sclerosis
Migraine & Headache
Psychiatry & Behavioral Health
Movement Disorders
Rare Neurological Diseases
ACCESS & AFFORDABILITY
Prior Authorization
Patient Assistance & Hubs
Biosimilars & Generics
Drug Pricing & Out-of-Pocket
Coverage & Appeals
MANAGED CARE
Formulary & Coverage
Value Based Care
Pharmacy Benefit Trends
Population Health Management
Payer Policy & Regulation
Biomarker & Genomic Testing
Lung & Thoracic
CHIP and Cardiovascular Risk: A Meta-Analysis
ESMO 2026 meta-analysis of five studies links clonal hematopoiesis to 28% higher lung cancer odds, rising to 48% with large clones and ASXL1 or DNMT3A mutation
Read the Story
Colorectal
Two Approved Blood Tests, One Guideline Update, and the Ongoing Adenoma Issue
Sep 5, 2026 | George Padron
GU Cancers
Urine Assay Outperforms MRI in Prostate Cancer Surveillance
Sep 2, 2026 | George Padron
Hematologic Malignancies
Imaging Alone May Spot the High-Risk Mediastinal Lymphoma Patient on Day One
Aug 6, 2026 | George Padron
Precision Medicine
Mapping Parkinson's Genetics Beyond European Ancestry
Aug 5, 2026 | George Padron
Alzheimer's & Dementia
A Blood Test's Blind Spots: Discrepancies Between P-tau217 and Clinical Alzheimer's Disease
Aug 1, 2026 | George Padron
GI Cancers
Barrett's Surveillance Shifts to a Risk-Based Footing
Jul 30, 2026 | George Padron
Load More
Latest News
Daily Aspirin Post-Colorectal Liver Metastasis Surgery Fails to Prevent Recurrence
Nov 2, 2026
Operator Characteristics as Determinants of Multi-Vessel Stenting Strategy in Canadian Acute Coronary Syndrome Management
Oct 30, 2026
Spanish Clinicians Highlight Discrepancies in Biologic Treatment Eligibility for Nasal Polyposis
Oct 29, 2026
GPRC5D-Directed Bispecific Antibody Achieves 21.8-Month Median PFS in Relapsed/Refractory Multiple Myeloma: ESMO 2026
Oct 28, 2026
Galectin-9 Antibody Shows Efficacy in Heavily Pretreated High-Risk MDS: Key Findings From ESMO 2026
Oct 27, 2026
Only Healthcare Today
Covering Clinical Healthcare, Access and Cost
1 Hewitt Square, Suite 139
East Northport, NY 11731
Who We Are
About Us
Editorial Policy
Contributors & Partners
Connect
Contact Us
Work With Us
Advertising
Terms of Use
Privacy Policy
x
Search